Board of Directors
 | Audit Committee Charter (PDF) | | Compensation Committee Charter (PDF) | |
Nominating Committee Charter (PDF) | ||
|
| |||||||
 = Committee Chair = Committee Member | Audit Committee | Compensation Committee | Nominating & Governance Committee |
|---|---|---|---|
| Ronald C. Renaud, Jr. President and CEO, Idenix Pharmaceuticals, Inc. |
|||
| Wayne T. Hockmeyer,
Ph.D. Former Chairman of the Board of Directors, MedImmune, Inc |
| | |
| Thomas R. Hodgson
* Former President and COO, Abbott Laboratories |
| ||
| Tamar Howson Former Interim CEO S*Bio |
| | |
| Denise Pollard-Knight,
Ph.D. Managing Partner, Phase4 Ventures |
| | |
| Anthony Rosenberg Global Head of Business Development and Licensing, Novartis Pharma AG |
|||
| Michael Wyzga President and CEO, Radius Health, Inc. |
| | |
* Chairman of the Board and Lead Director
Idenix has focused its efforts towards HCV due to the global unmet medical need for this viral disease. It is estimated that more than 170 million people worldwide are chronically infected with HCV.